The cell-surface serine protease known as fibroblast activation protein (FAP) affects different hormones and elements of the extracellular matrix. FAP is frequently used as a marker for pro-tumorigenic stroma and is highly upregulated in a variety of cancers.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V125308 | 3BP-3580 | 2374782-82-6 | 3BP-3580 is a fibroblast activating protein (FAP) inhibitor (pIC50: 8.6) that can be used in cancer research. |
|
V86175 | 3BP-3940 | 2803421-14-7 | 3BP-3940 is a highly effective fibroblast activating protein (FAP) targeting peptide. |
|
V125309 | 3BP-4089 | 2581199-35-9 | 3BP-4089 is a highly effective fibroblast activating protein (FAP) targeting peptide. |
|
V125310 | 3BP-4089 TFA | 3BP-4089 TFA is a highly effective fibroblast activation protein (FAP) targeting peptide. | |
|
V86846 | [99mTc]Tc-6–1 | [99m Tc]Tc-6-1 is a 99mTc-labeled FAPI-46 derivative and a specific fibroblast activation protein (FAP) targeted radiotracer. | |
|
V85878 | AlF-PD-FAPI | AlF-PD-FAPI has an affinity for FAP with an IC50 value of 0.13 nM. It also exhibits specific uptake, high internalization rate, and low extracellular excretion in vitro, making it suitable as a targeted tracer for FAP. | |
|
V129722 | AZD2389 | 2791472-12-1 | AZD2389 is a potent and orally effective FAP inhibitor. |
|
V131858 | CL 118326 | 97012-61-8 | CL 118326 is a potent, selective competitive inhibitor of mammalian pancreatic phospholipase A2 (PLA2) and a weak antagonist of platelet-activating factor receptor (PAF receptor). |
|
V133086 | Cys-FAP targeting peptide for FXX489 | Cys-FAP targeting peptide for FXX489 is the unlabeled peptide portion of FXX489. | |
|
V133087 | Cys-FAP targeting peptide for FXX489 TFA | Cys-FAP targeting peptide for FXX489 TFA is the unlabeled peptide moiety of FXX489. | |
|
V118440 | DOTA-2P (FAPI)2 | DOTA-2P(FAPI)2 is a dimeric FAP (fibroblast activating protein) targeting radioactive probe that can be used as a tracer for PET imaging and tumor targeting. | |
|
V119240 | DOTA-ALB-01 | DOTA-ALB-01 is an albumin-bound FAP inhibitor (FAPI) ligand. | |
|
V119214 | DOTA-ALB-02 | DOTA-ALB-02 is an albumin-bound FAP inhibitor (FAPI) ligand. | |
|
V134275 | DOTA-C1-FAP-2286 | 3107530-08-2 | DOTA-C1-FAP-2286 is a cysteine-modified fibroblast activating protein (FAP) targeting radioligand. |
|
V134281 | DOTA-NI-FAPI-04 | 3078291-78-5 | DOTA-NI-FAPI-04 is an FAP inhibitor (IC50 = 7.44 nM). |
|
V93849 | DOTAGA.(SA.FAPi)2 analogue TFA | DOTAGA.(SA.FAPi)2 analog TFA is an analog of DOTAGA.(SA.FAPi)2 TFA, wherein the ligand and chelator moieties are the same as DOTAGA.(SA.FAPi)2 TFA. | |
|
V94503 | DOTAGA.(SA.FAPi)2 TFA | DOTAGA.(SA.FAPi)2 TFA is a potent inhibitor of dimeric fibroblast activation protein (FAPi). | |
|
V134277 | DOTAGA.Glu.(FAPi)2 | 2882922-68-9 | DOTAGA.Glu.(FAPi)2 is a FAPI homodimer in which a glutamic acid (Glu) linker connects FAPI and a chelating agent. |
|
V135755 | FAP Ligand 2 | FAP Ligand 2 is a derivative of FAPI-46 and a tracer that specifically targets fibroblast activation protein (FAP). | |
|
V135756 | FAP Ligand 3 | FAP Ligand 3 is a reagent that can bind to FAP, with a Ki value of 0.092 nM for human targets. |